L-Base
L-Base, licence 02244083: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Monnol Import Export Inc.
- NPN or DIN-HM
- 02244083
- Status
- Inactive licence
- Licence date
- 29 December 2009
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- DIN de transition
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Lactobacillus acidophilus Source : Lactobacillus acidophilus - Cellule entière | 1000000000.0 ufc | Not calculated |
Non-medicinal ingredients
Hypromellose, Acide silicique, Foeniculum vulgare, Talc, Elettaria cardamomum, Monoditriglycerides, Charbon végétal, Maltodextrine, Amidon du riz
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2.0 Capsule | minimum: 3.0 Jour(s) ; maximum: 4.0 Jour(s) |
Uses authorised in Canada
Pour reconstituer, normaliser ou stabilisant la flore intestinale.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Une hypersensibilité (e.g. une allergie) peut se manifester (quelques rares, cas ont été rapportées). Si tel est le cas, cesser l'utilisation.
Source
Official Health Canada record, licence 02244083
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.